NIPT Market Landscape and Strategy
Clinical Diagnostics
20
10
3
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Go-to-Market Strategy
Objective
A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.
Our Approach
Secondary Research
- Determined key drivers and barriers affecting stakeholder adoption of in-house NIPT testing based on lab type, hospital size, and rates of prenatal care
- Analyzed stakeholder feedback on three potential test profiles to determine strengths and weaknesses of test specifications, workflow, and technology
- Outlined customer profiles of stakeholders more likely to favor certain testing profiles and recommended tactics to drive adoption within these groups
Primary Research
- Assessed existing knowledge base of stakeholders regarding prenatal testing paradigms, including gaps in knowledge that limit current attractiveness of in-house testing
- Interviewees included lab personnel working across reference labs and hospital labs who conduct in-house women’s health molecular testing
Outcome
DeciBio shared research findings with the client, key takeaways included:
- Likelihood of adoption of in-house NIPT tests based on lab type and potential avenues to drive adoption in current testing paradigm
- Quantitative feedback on potential testing solutions and recommendations for improvements to increase test competitiveness
Related Client Results
Genetic Testing Company Assessment
Target Identification
Longitudinal Monitoring of Cancer Early Detection Market
Competitive Analysis
PE-Backed Life Sciences Tools Platform Development
Voice-of-Customer Research
Customer Segmentation
Pricing Strategy
Due Diligence
Competitive Analysis
